Tag: Cancer: Prostate
Testosterone Seems Safe for Hypogonadal Prostate CA Patients
Testosterone therapy seems oncologically safe after treatment or for those on active surveillance
Outlook Good for Localized Prostate CA, Despite Tx Chosen
Survival rates high for active surveillance, radiation, or prostatectomy
PSA Failure Predicts Death in Men With No, Minimal Comorbidity
Findings among men with localized intermediate- and high-risk prostate cancer
Decision Regret Uncommon After Radical Prostatectomy, IMRT
Overall decision regret for 16.9 percent of patients; more regret for RP than radiotherapy component
USPSTF Ruling Followed by Fall in Early Prostate Cancer Diagnoses
Rates per 100,000 men have dropped from 356.5 to 335.4 in men aged 50 to 74
Sociodemographic Factors Affect Prostate CA Treatment Initiation
Non-Hispanic black men more likely to begin active treatment, independent of clinical measures
Predictors ID’d for Switching to Active Tx in Prostate Cancer
Ethnicity influences patient decision to pursue active treatment and serial biopsies in active surveillance
QOL Not Affected by Active Surveillance of Prostate Cancer
Choosing no treatment and regular check-ups didn't seem to stress men with low-risk disease
Similar Outcomes for Robot-Assisted, Radical Prostatectomy
Similar functional outcomes at 12 weeks post-surgery for newly diagnosed localized prostate CA
Metastatic Prostate Cancer Cases Increasing in the United States
Findings highlight continued need for nationwide refinements in prostate cancer screening
